Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الحياة للصناعات الدوائية - hayat pharmaceutical industries co.plc - pentoxifylline 400 mg - 400 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الحياة للصناعات الدوائية - hayat pharmaceutical industries co.plc - pentoxifylline 400 mg - 400 mg

United Kingdom - English - myHealthbox

pharmachemie b.v. - etoposide, ph.eur. - concentrate for solution for infusion (to dilute). - 20mg/ml - podophyllotoxine derivatives - for the management of: - testicular tumours in combination with other chemotherapeutic agents - small cell lung cancer, in combination with other chemotherapeutic agents - monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard therapy has failed (in combination with other chemotherapeutic agents).

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - dihydroergotoxine mesilate - tablets - 1.5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - dihydroergotoxine mesilate - tablets - 4.5 milligram

India - English - Central Drugs Standard Control Organization

sun - dihydroergotoxine(codergocrine) - tab - 1 mg - 10

India - English - Central Drugs Standard Control Organization

novartis - dihydroergotoxine(codergocrine) - tab - 1 mg - 3 x30

India - English - Central Drugs Standard Control Organization

novartis - dihydroergotoxine(codergocrine) - inj - 0.3 ml/ml - 6*1 ml

Singapore - English - HSA (Health Sciences Authority)

atlantic pharmaceutical (s) pte ltd - dihydroergotoxine mesylate - tablet - 1 mg

Singapore - English - HSA (Health Sciences Authority)

yung shin pharmaceutical (singapore) pte ltd - dihydroergotoxine mesylate - tablet - 1.5 mg